Bill Requiring Justification For Rx Price Hikes Clears House Cmte.
Executive Summary
House Ways & Means Committee clears legislation requiring manufacturers to justify 10% WAC increase in one year and 25% increase over three years, and to report number of free product samples.
You may also be interested in...
House Committee Clears Bills To Prevent Pay-For-Delay Deals, Assure Generic Access To Samples
Legislation on patent settlement agreements will not be retroactive; CREATES Act amended to give brand companies affirmative defense to litigation.
Mylan Communications With CMS To Get Outside Review Under EpiPen Settlement
Corporate integrity agreement requires Mylan to have an independent body review its drug classifications and US best price determinations; settlement resolves claims Mylan misclassified EpiPen to underpay rebates. Sanofi acted as whistleblower in case.